HuGE Literature Finder
Records
1
-
30
| DPYD polymorphisms c.496A>G, c.2194G>A and c.85T>C and risk of severe adverse drug reactions in patients treated with fluoropyrimidine-based protocols. British journal of clinical pharmacology 2021 Nov . Božina Nada, Bili? Ivan, Ganoci Lana, Šimi?evi? Livija, Pleština Stjepko, Lešnjakovi? Lucija, Trkulja Vladim |
| Dihydropyrimidine dehydrogenase (DPYD) gene c.1627A>G A/G and G/G genotypes are risk factors for lymph node metastasis and distant metastasis of colorectal cancer. Journal of clinical laboratory analysis 2021 Oct e24023. Zeng Juanzi, Wu Heming, Huang Qingyan, Li Jiaquan, Yu Zhikang, Zhong Zhixio |
| A case-control study of a combination of single nucleotide polymorphisms and clinical parameters to predict clinically relevant toxicity associated with fluoropyrimidine and platinum-based chemotherapy in gastric cancer. BMC cancer 2021 Sep 21 (1): 1030. Cordova-Delgado Miguel, Bravo María Loreto, Cumsille Elisa, Hill Charlotte N, Muñoz-Medel Matías, Pinto Mauricio P, Retamal Ignacio N, Lavanderos María A, Miquel Juan Francisco, Rodriguez-Fernandez Maria, Liao Yuwei, Li Zhiguang, Corvalán Alejandro H, Armisén Ricardo, Garrido Marcelo, Quiñones Luis A, Owen Gareth |
| Comprehensive pharmacogenetic analysis of DPYD, UGT, CDA, and ABCB1 polymorphisms in pancreatic cancer patients receiving mFOLFIRINOX or gemcitabine plus nab-paclitaxel. The pharmacogenomics journal 2021 Jan . Vivaldi Caterina, Crucitta Stefania, Catanese Silvia, Cucchiara Federico, Arrigoni Elena, Pecora Irene, Rofi Eleonora, Fornaro Lorenzo, Salani Francesca, Massa Valentina, Vasile Enrico, Morganti Riccardo, Danesi Romano, Del Re Marz |
| Decoding variants in drug-metabolizing enzymes and transporters in solid tumor patients by whole-exome sequencing. Saudi journal of biological sciences 2021 Jan 28 (1): 628-634. Aboul-Soud Mourad A M, Alzahrani Alhussain J, Mahmoud Am |
| Identification of a Four-lncRNA Prognostic Signature for Colon Cancer Based on Genome Instability. Journal of oncology 2021 2021 7408893. Yun Duo, Yang Zhiro |
| Whole Exome Sequencing in BRCA1-2 Candidate Families: The Contribution of Other Cancer Susceptibility Genes. Frontiers in oncology 2021 11 649435. Doddato Gabriella, Valentino Floriana, Giliberti Annarita, Papa Filomena Tiziana, Tita Rossella, Bruno Lucia Pia, Resciniti Sara, Fallerini Chiara, Benetti Elisa, Palmieri Maria, Mencarelli Maria Antonietta, Fabbiani Alessandra, Bruttini Mirella, Orrico Alfredo, Baldassarri Margherita, Fava Francesca, Lopergolo Diego, Lo Rizzo Caterina, Lamacchia Vittoria, Mannucci Sara, Pinto Anna Maria, Curr Aurora, Mancini Virginia, , , Mari Francesca, Renieri Alessandra, Ariani Frances |
| Predictive value of clinical toxicities of chemotherapy with fluoropyrimidines and oxaliplatin in colorectal cancer by DPYD and GSTP1 gene polymorphisms. World journal of surgical oncology 2020 Dec 18 (1): 321. Deng Xunwei, Hou Jingyuan, Deng Qiaoting, Zhong Zhixio |
| [Analysis of carrying clinically significant allelic variants of TPMT and DPYD genes associated with the response to drug therapy in cancer practice among 9 ethnic groups of the Russian Federation]. Terapevticheskii arkhiv 2020 Sep 92 (8): 43-51. Mirzaev K B, Fedorinov D S, Akmalova K A, Abdullaev S P, Kachanova A A, Sozaeva Z A, Grishina E A, Shuev G N, Kitaeva E Y, Shprakh V V, Suleymanov S S, Bolieva L Z, Sozaeva M S, Zhuchkova S M, Gimaldinova N E, Sidukova E E, Burashnikova I S, Shikaleva A A, Zabudskaya K G, Sychev D |
| Effect of drug metabolizing enzymes and transporters in Thai colorectal cancer patients treated with irinotecan-based chemotherapy. Scientific reports 2020 Aug 10 (1): 13486. Atasilp Chalirmporn, Chansriwong Phichai, Sirachainan Ekaphop, Reungwetwattana Thanyanan, Sirilerttrakul Suwannee, Chamnanphon Monpat, Puangpetch Apichaya, Sukasem Chonlaph |
| Germline and Somatic Pharmacogenomics to Refine Rectal Cancer Patients Selection for Neo-Adjuvant Chemoradiotherapy. Frontiers in pharmacology 2020 897. De Mattia Elena, Roncato Rossana, Palazzari Elisa, Toffoli Giuseppe, Cecchin Eri |
| Impact of DPYD, DPYS, and UPB1 gene variations on severe drug-related toxicity in patients with cancer. Cancer science 2020 Jul . Yokoi Katsuyuki, Nakajima Yoko, Matsuoka Hiroshi, Shinkai Yasuko, Ishihara Takuma, Maeda Yasuhiro, Kato Takema, Katsuno Hidetoshi, Masumori Koji, Kawada Kenji, Yoshikawa Tetsushi, Ito Tetsuya, Kurahashi Hiro |
| Clinical evaluation of germline polymorphisms associated with capecitabine toxicity in breast cancer: TBCRC-015. Breast cancer research and treatment 2020 May . O'Donnell Peter H, Trubetskoy Vassily, Nurhussein-Patterson Ashley, Hall Julianne P, Nath Aritro, Huo Dezheng, Fleming Gini F, Ingle James N, Abramson Vandana G, Morrow P K, Storniolo Anna Maria, Forero Andres, Van Poznak Catherine, Liu Minetta C, Chang Jenny C, Merkel Douglas E, Peppercorn Jeffrey M, Rugo Hope S, Dees E Claire, Hahn Olwen M, Hoffman Philip C, Rosner Gary L, Huang R Stephanie, Ratain Mark J, Cox Nancy, Olopade Olufunmilayo I, Wolff Antonio C, Dolan M Eileen, Nanda Rita, |
| Genetic 3'UTR variations and clinical factors significantly contribute to survival prediction and clinical response in breast cancer patients. Scientific reports 2020 Mar 10 (1): 5736. Pamula-Pilat Jolanta, Tecza Karolina, Kalinowska-Herok Magdalena, Grzybowska E |
| Polymorphisms of xenobiotic-metabolizing and transporter genes, and the risk of gastric and colorectal cancer in an admixed population from the Brazilian Amazon. American journal of translational research 2020 12 (10): 6626-6636. de Castro Amanda Nazaré Cohen Lima, Fernandes Marianne Rodrigues, de Carvalho Darlen Cardoso, de Souza Tatiane Piedade, Rodrigues Juliana Carla Gomes, Andrade Roberta Borges, Modesto Antonio Andre Conde, Santos Sidney, Assumpção Paulo Pimentel, Dos Santos Ney Pereira Carnei |
| Retracted: Influence of DPYD Genetic Polymorphisms on 5-Fluorouracil Toxicities in Patients with Colorectal Cancer: A Meta-Analysis. Gastroenterology research and practice 2020 2020 9470819. Research And Practice Gastroenterolo |
| Influence of DPYD*9A, DPYD*6 and GSTP1 ile105val Genetic Polymorphisms on Capecitabine and Oxaliplatin (CAPOX) Associated Toxicities in Colorectal Cancer (CRC) Patients. Asian Pacific journal of cancer prevention : APJCP 2019 Oct 20 (10): 3093-3100. Varma K Ashok, Jayanthi M, Dubashi Biswajit, Shewade D |
| The Prevalence of DPYD*9A(c.85T>C) Genotype and the Genotype-Phenotype Correlation in Patients with Gastrointestinal Malignancies Treated With Fluoropyrimidines: Updated Analysis. Clinical colorectal cancer 2019 May . Maharjan Anu Singh, McMillin Gwendolyn A, Patel Girijesh Kumar, Awan Saad, Taylor William R, Pai Sachin, Frankel Arthur E, Nelson Cindy, Wang Bin, Hosein Peter Joel, Singh Ajay P, Khushman Moh |
| The Genotype for DPYD Risk Variants in Patients With Colorectal Cancer and the Related Toxicity Management Costs in Clinical Practice. Clinical pharmacology and therapeutics 2019 Apr 105 (4): 994-1002. Toffoli Giuseppe, Innocenti Federico, Polesel Jerry, De Mattia Elena, Sartor Franca, Dalle Fratte Chiara, Ecca Fabrizio, Dreussi Eva, Palazzari Elisa, Guardascione Michela, Buonadonna Angela, Foltran Luisa, Garziera Marica, Bignucolo Alessia, Nobili Stefania, Mini Enrico, Favaretto Adolfo, Berretta Massimiliano, D'Andrea Mario, De Paoli Antonino, Roncato Rossana, Cecchin Eri |
| DPYD, TYMS and MTHFR Genes Polymorphism Frequencies in a Series of Turkish Colorectal Cancer Patients. Journal of personalized medicine 2018 Dec 8 (4): . Amirfallah Arsalan, Kocal Gizem Calibasi, Unal Olcun Umit, Ellidokuz Hulya, Oztop Ilhan, Basbinar Yasem |
| Early disease relapse in a patient with colorectal cancer who harbors genetic variants of DPYD, TYMS, MTHFR and DHFR after treatment with 5-fluorouracil-based chemotherapy. Drug metabolism and personalized therapy 2018 Sep . Zawiah Mohammed, Yousef Al-Motassem, Kadi Taha, Yousef Mohammed, Majdalawi Khalil, Al-Yacoub Shorouq, Al-Hiary Rasha, Tantawi Dua'a, Mukred Ramzi, Ajaj Abdel Rahm |
| Germline pharmacogenomics of DPYD*9A (c.85T>C) variant in patients with gastrointestinal malignancies treated with fluoropyrimidines. Journal of gastrointestinal oncology 2018 Jun 9 (3): 416-424. Khushman Moh'd, Patel Girijesh Kumar, Hosein Peter Joel, Laurini Javier Ariel, Cameron Daniel, Clarkson David Roland, Butler Thomas Wayne, Norden Carole Wiseman, Baliem Wilma, Jones Vanessa, Bhadkamkar Sanjyot, Nelson Cindy, Lee Frances, Singh Ajay P, Taylor William |
| Preliminary Evidence for Enhanced Thymine Absorption: A Putative New Phenotype Associated With Fluoropyrimidine Toxicity in Cancer Patients. Therapeutic drug monitoring 2018 May . Duley John A, Ni Ming, Shannon Catherine, Norris Ross L, Sheffield Leslie, Cowley David, Harris Marion, van Kuilenburg André B P, Helsby Nuala, George Rani, Charles Bruce |
| The association of polymorphisms in folate-metabolizing genes with response to adjuvant chemotherapy of colorectal cancer. Cancer chemotherapy and pharmacology 2018 May . Yousef Al-Motassem, Zawiah Mohammed, Al-Yacoub Shorouq, Kadi Taha, Tantawi Dua' A, Al-Ramadhani Hangu |
| Pharmacogenetics of toxicity of 5-fluorouracil, doxorubicin and cyclophosphamide chemotherapy in breast cancer patients. Oncotarget 2018 Feb 9 (10): 9114-9136. Tecza Karolina, Pamula-Pilat Jolanta, Lanuszewska Joanna, Butkiewicz Dorota, Grzybowska E |
| DPYD and UGT1A1 genotyping to predict adverse events during first-line FOLFIRI or FOLFOXIRI plus bevacizumab in metastatic colorectal cancer. Oncotarget 2018 Jan 9 (8): 7859-7866. Cremolini Chiara, Del Re Marzia, Antoniotti Carlotta, Lonardi Sara, Bergamo Francesca, Loupakis Fotios, Borelli Beatrice, Marmorino Federica, Citi Valentina, Cortesi Enrico, Moretto Roberto, Ronzoni Monica, Tomasello Gianluca, Zaniboni Alberto, Racca Patrizia, Buonadonna Angela, Allegrini Giacomo, Ricci Vincenzo, Di Donato Samantha, Zagonel Vittorina, Boni Luca, Falcone Alfredo, Danesi Roma |
| Clinical Value of Pharmacogenomic Testing in a Patient Receiving FOLFIRINOX for Pancreatic Adenocarcinoma. Frontiers in pharmacology 2018 9 1309. Velez-Velez Lisa M, Hughes Caren L, Kasi Pashtoon Murta |
| TYMS 2R3R polymorphism and DPYD [IVS]14+1G>A gene mutation in Mexican colorectal cancer patients. Acta biochimica Polonica 2018 65 (2): 227-234. Gallegos-Arreola Martha Patricia, Zúñiga-González Guillermo Moisés, Sánchez-López Josefina Yoaly, Cruz Alondra Yeraldi Naranjo, Peralta-Leal Valeria, Figuera Luis Eduardo, Puebla-Pérez Ana María, Ronquillo-Carreón Carlos Alberto, Puebla-Mora Ana Gracie |
| DPYD genotype and haplotype analysis and colorectal cancer susceptibility in a case-control study from Slovakia. General physiology and biophysics 2017 Dec 36 (5): 557-563. Matáková Tatiana, Halašová Erika, Škovierová Henrieta, Dzian Anton, Dobrota Dušan, Škere?ová Már |
| The Role of Dihydropyrimidine Dehydrogenase and Thymidylate Synthase Polymorphisms in Fluoropyrimidine-Based Cancer Chemotherapy in an Iranian Population. Avicenna journal of medical biotechnology 0 12 (3): 157-164. Abbasian Mohammad Hadi, Ansarinejad Nafiseh, Abbasi Bahareh, Iravani Masoud, Ramim Tayeb, Hamedi Fahime, Ardekani Ali |
- Page last reviewed:Oct 1, 2021
- Page last updated:Jan 20, 2022
- Content source: